Food Effect Study of VHX-896 in Healthy Volunteers
NCT06803290 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 24
Last updated 2025-01-31
Summary
A single center, two-period, randomized study to evaluate the food effect of VHX-896 tablets in healthy volunteers
Conditions
- Healthy
Interventions
- DRUG
-
VHX-896
Oral tablet
Sponsors & Collaborators
- lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Max Age
- 55 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2022-06-21
- Primary Completion
- 2022-12-27
- Completion
- 2022-12-27
- FDA Drug
- Yes
Countries
- United States
Study Locations
More Related Trials
-
Clinical Study to Evaluate Pharmacokinetic Profiles and Safety of CKD-387 Under Fasting Condition
NCT05673369 ·Status: COMPLETED ·Phase: PHASE1
-
The Food Effect on the Pharmacokinetics of NVP-1402
NCT03340480 ·Status: COMPLETED ·Phase: PHASE1
-
A Study Assessing the Mass Balance, Pharmacokinetics, and Metabolite Profiles of a Single Oral Dose of [14C]INCB099280 in Healthy Male Participants
NCT06309394 ·Status: COMPLETED ·Phase: PHASE1
-
A Pharmacokinetic Study of Omaveloxolone in Healthy Volunteers
NCT03664453 ·Status: COMPLETED ·Phase: PHASE1
-
2-HOBA: Multiple Dosing Study in Healthy Humans
NCT03555682 ·Status: COMPLETED ·Phase: NA
-
Clinical Study to Evaluate the Pharmacokinetic Profiles and Safety of CKD-387 in Healthy Volunteers Under Fasting Conditions
NCT06399055 ·Status: COMPLETED ·Phase: PHASE1
-
Effect of Food on the Pharmacokinetics of BI 1060469 (Formulation Tablet) in Healthy Male Subjects
NCT02225626 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate Metabolism, Excretion, and Mass Balance of [14C]Vapendavir
NCT06834295 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Study to Evaluate Effect of Verapamil and Food of Sevasemten in Healthy Volunteers
NCT06916897 ·Status: COMPLETED ·Phase: PHASE1
-
A Study in Healthy Subjects to Evaluate Pharmacokinetics and Food Effect After Dosing of GS-248
NCT04617509 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate the Effect of Particle Size, Formulation and Food on the Pharmacokinetics of GDC-0032 in Healthy Volunteers
NCT01980953 ·Status: COMPLETED ·Phase: PHASE1
-
The Pharmacokinetics of D565 and the Drug Effect of D565 on Pharmacokinetic Characteristics of D930
NCT03034486 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmacokinetic Study of CXB909 in Healthy Male Subjects
NCT01505907 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
A Bioavailability and Pharmacokinetic Study of GDC-0032 in Healthy Volunteers
NCT01967966 ·Status: COMPLETED ·Phase: PHASE1
-
A Phase 1 Study of CDX-0159
NCT04146129 ·Status: COMPLETED ·Phase: PHASE1
-
A Trial of SHR6390 in Healthy Caucasian Volunteers
NCT04301804 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of the Absorption, Metabolism and Excretion of [14C]XZP-3621 in Human
NCT05836805 ·Status: UNKNOWN ·Phase: PHASE1
-
Pharmacokinetics and Safety/Tolerability After Oral Administration of CKD-387 and D635 in Healthy Adults
NCT03849261 ·Status: UNKNOWN ·Phase: PHASE1
-
A Study to Investigate the Effect of Food, Gender, and Age on the Pharmacokinetic Profile of SUVN-G3031 in Healthy Subjects
NCT02881294 ·Status: COMPLETED ·Phase: PHASE1
-
Effects of Tradipitant on Satiation, Gastric Volume, Gastric Accommodation, and Gastric Emptying in Healthy Volunteers
NCT04849559 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Pharmacokinetics and Safety/Tolerability After Oral Administration of CKD-387 and D635 Under Fed Condition
NCT03849339 ·Status: UNKNOWN ·Phase: PHASE1
-
Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of High-dose CKD-385 in Healthy Volunteers(Fed)
NCT04083846 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate How the Body Processes 14C-VX-993 After a Single Oral Dose
NCT06886269 ·Status: COMPLETED ·Phase: PHASE1
-
An Investigational Study of SHR6390 in Participants With Mild to Moderate Liver Impairment and Healthy Participants
NCT04631575 ·Status: UNKNOWN ·Phase: PHASE1
-
Safety, Tolerability and Pharmacokinetics of BI 34021 FU2 Oral Drinking Solution in Healthy Male Volunteers
NCT02259842 ·Status: COMPLETED ·Phase: PHASE1